nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—Doxorubicin—bone cancer	0.456	0.5	CbGbCtD
L-Arginine—NOS2—Doxorubicin—bone cancer	0.456	0.5	CbGbCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.0039	0.0847	CbGpPWpGaD
L-Arginine—Extravasation—Carboplatin—bone cancer	0.00349	0.121	CcSEcCtD
L-Arginine—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—DHFR—bone cancer	0.00276	0.06	CbGpPWpGaD
L-Arginine—NOS3—hindlimb—bone cancer	0.00272	0.193	CbGeAlD
L-Arginine—Skin necrosis—Cisplatin—bone cancer	0.00255	0.0886	CcSEcCtD
L-Arginine—NOS3—appendage—bone cancer	0.00233	0.166	CbGeAlD
L-Arginine—NOS3—Metabolism of nitric oxide—DHFR—bone cancer	0.00191	0.0415	CbGpPWpGaD
L-Arginine—NOS2—tendon—bone cancer	0.00166	0.118	CbGeAlD
L-Arginine—Skin necrosis—Methotrexate—bone cancer	0.0014	0.0486	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.00131	0.0285	CbGpPWpGaD
L-Arginine—Skin necrosis—Epirubicin—bone cancer	0.00131	0.0455	CcSEcCtD
L-Arginine—AZIN2—tendon—bone cancer	0.00126	0.0894	CbGeAlD
L-Arginine—Skin necrosis—Doxorubicin—bone cancer	0.00121	0.0421	CcSEcCtD
L-Arginine—AZIN2—spinal cord—bone cancer	0.00121	0.0862	CbGeAlD
L-Arginine—Necrosis—Cisplatin—bone cancer	0.00114	0.0394	CcSEcCtD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00106	0.0231	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00103	0.0224	CbGpPWpGaD
L-Arginine—Extravasation—Cisplatin—bone cancer	0.00102	0.0355	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.000966	0.021	CbGpPWpGaD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—GNA11—bone cancer	0.00093	0.0202	CbGpPWpGaD
L-Arginine—Skin exfoliation—Cisplatin—bone cancer	0.000852	0.0295	CcSEcCtD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—GNA11—bone cancer	0.000753	0.0164	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NDUFA12—bone cancer	0.000729	0.0158	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.000705	0.0153	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NDUFA12—bone cancer	0.000667	0.0145	CbGpPWpGaD
L-Arginine—NOS3—connective tissue—bone cancer	0.000665	0.0474	CbGeAlD
L-Arginine—ARG2—tendon—bone cancer	0.000655	0.0466	CbGeAlD
L-Arginine—ARG2—spinal cord—bone cancer	0.000631	0.0449	CbGeAlD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—bone cancer	0.000624	0.0135	CbGpPWpGaD
L-Arginine—Necrosis—Methotrexate—bone cancer	0.000624	0.0216	CcSEcCtD
L-Arginine—AZIN2—Metabolism—NT5C3A—bone cancer	0.000604	0.0131	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—RGS1—bone cancer	0.000597	0.013	CbGpPWpGaD
L-Arginine—Necrosis—Epirubicin—bone cancer	0.000584	0.0203	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.000567	0.0123	CbGpPWpGaD
L-Arginine—Extravasation—Methotrexate—bone cancer	0.000561	0.0195	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—PLAU—bone cancer	0.000553	0.012	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NDUFA12—bone cancer	0.000553	0.012	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NT5C3A—bone cancer	0.000553	0.012	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00055	0.0119	CbGpPWpGaD
L-Arginine—Necrosis—Doxorubicin—bone cancer	0.00054	0.0187	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—IGF1R—bone cancer	0.000534	0.0116	CbGpPWpGaD
L-Arginine—Extravasation—Epirubicin—bone cancer	0.000525	0.0182	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—CDK4—bone cancer	0.000523	0.0114	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MMP9—bone cancer	0.000523	0.0113	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000511	0.0111	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000511	0.0111	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—GNA11—bone cancer	0.000506	0.011	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—bone cancer	0.000492	0.0107	CbGpPWpGaD
L-Arginine—Extravasation—Doxorubicin—bone cancer	0.000486	0.0169	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000474	0.0103	CbGpPWpGaD
L-Arginine—Skin exfoliation—Methotrexate—bone cancer	0.000467	0.0162	CcSEcCtD
L-Arginine—ASS1—tendon—bone cancer	0.000459	0.0327	CbGeAlD
L-Arginine—ARG2—Metabolism—NT5C3A—bone cancer	0.000458	0.00994	CbGpPWpGaD
L-Arginine—NOS3—tendon—bone cancer	0.000457	0.0326	CbGeAlD
L-Arginine—Injection site reaction—Epirubicin—bone cancer	0.000455	0.0158	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—RB1—bone cancer	0.000454	0.00987	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000453	0.00984	CbGpPWpGaD
L-Arginine—ASS1—spinal cord—bone cancer	0.000443	0.0315	CbGeAlD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000441	0.00958	CbGpPWpGaD
L-Arginine—Skin exfoliation—Epirubicin—bone cancer	0.000437	0.0152	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—MMP2—bone cancer	0.000436	0.00947	CbGpPWpGaD
L-Arginine—Injection site reaction—Doxorubicin—bone cancer	0.000421	0.0146	CcSEcCtD
L-Arginine—Flushing—Cisplatin—bone cancer	0.000416	0.0144	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—bone cancer	0.000405	0.014	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—MMP2—bone cancer	0.000399	0.00866	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—bone cancer	0.000386	0.00839	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NDUFA12—bone cancer	0.000383	0.00832	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—bone cancer	0.00038	0.00825	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bone cancer	0.00037	0.00803	CbGpPWpGaD
L-Arginine—Lethargy—Methotrexate—bone cancer	0.000363	0.0126	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—GNA11—bone cancer	0.000349	0.00758	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—EZH2—bone cancer	0.000347	0.00754	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.00034	0.00739	CbGpPWpGaD
L-Arginine—Lethargy—Epirubicin—bone cancer	0.000339	0.0118	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000338	0.00733	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—JUN—bone cancer	0.000337	0.00732	CbGpPWpGaD
L-Arginine—SLC16A10—tendon—bone cancer	0.000328	0.0233	CbGeAlD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—bone cancer	0.000321	0.00696	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Cisplatin—bone cancer	0.000318	0.011	CcSEcCtD
L-Arginine—ASS1—Metabolism—NT5C3A—bone cancer	0.000317	0.00689	CbGpPWpGaD
L-Arginine—Lethargy—Doxorubicin—bone cancer	0.000314	0.0109	CcSEcCtD
L-Arginine—Tachycardia—Cisplatin—bone cancer	0.000311	0.0108	CcSEcCtD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—ATF1—bone cancer	0.00031	0.00673	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MMP2—bone cancer	0.000309	0.00672	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—JUN—bone cancer	0.000308	0.00669	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000308	0.00669	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Cisplatin—bone cancer	0.000308	0.0107	CcSEcCtD
L-Arginine—Anorexia—Cisplatin—bone cancer	0.000303	0.0105	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—CDK4—bone cancer	0.0003	0.00652	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MMP9—bone cancer	0.0003	0.00651	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ATF1—bone cancer	0.000299	0.0065	CbGpPWpGaD
L-Arginine—SLC22A4—tendon—bone cancer	0.000292	0.0208	CbGeAlD
L-Arginine—SLC22A4—bone marrow—bone cancer	0.000283	0.0201	CbGeAlD
L-Arginine—SLC22A4—spinal cord—bone cancer	0.000282	0.02	CbGeAlD
L-Arginine—Decreased appetite—Cisplatin—bone cancer	0.000277	0.0096	CcSEcCtD
L-Arginine—AZIN2—Metabolism—ENO2—bone cancer	0.000265	0.00575	CbGpPWpGaD
L-Arginine—Sweating—Methotrexate—bone cancer	0.000262	0.00911	CcSEcCtD
L-Arginine—Haematuria—Methotrexate—bone cancer	0.000261	0.00906	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—RB1—bone cancer	0.000261	0.00567	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—BRAF—bone cancer	0.000252	0.00547	CbGpPWpGaD
L-Arginine—Sweating—Epirubicin—bone cancer	0.000246	0.00852	CcSEcCtD
L-Arginine—AZIN2—Metabolism—DHFR—bone cancer	0.000246	0.00533	CbGpPWpGaD
L-Arginine—Haematuria—Epirubicin—bone cancer	0.000244	0.00848	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—EGFR—bone cancer	0.000242	0.00526	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ENO2—bone cancer	0.000242	0.00526	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000239	0.0052	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—bone cancer	0.000239	0.0052	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—JUN—bone cancer	0.000239	0.00519	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000235	0.00511	CbGpPWpGaD
L-Arginine—Hypersensitivity—Cisplatin—bone cancer	0.000234	0.00814	CcSEcCtD
L-Arginine—NOS3—AGE/RAGE pathway—MMP9—bone cancer	0.000233	0.00505	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GNA11—bone cancer	0.000229	0.00498	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Epirubicin—bone cancer	0.000229	0.00794	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—bone cancer	0.000227	0.00789	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—bone cancer	0.000226	0.00784	CcSEcCtD
L-Arginine—ASL—Metabolism—DHFR—bone cancer	0.000225	0.00488	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—bone cancer	0.000215	0.00466	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.000214	0.00466	CbGpPWpGaD
L-Arginine—Flushing—Epirubicin—bone cancer	0.000213	0.00741	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—bone cancer	0.000212	0.00735	CcSEcCtD
L-Arginine—ASL—Metabolism—GNA11—bone cancer	0.00021	0.00456	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—bone cancer	0.000208	0.00453	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP3A4—bone cancer	0.000208	0.00452	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000207	0.00449	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000203	0.00441	CbGpPWpGaD
L-Arginine—Vomiting—Cisplatin—bone cancer	0.000202	0.00702	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—bone cancer	0.000201	0.00436	CbGpPWpGaD
L-Arginine—Rash—Cisplatin—bone cancer	0.000201	0.00696	CcSEcCtD
L-Arginine—ARG2—Metabolism—ENO2—bone cancer	0.000201	0.00436	CbGpPWpGaD
L-Arginine—Dermatitis—Cisplatin—bone cancer	0.0002	0.00696	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—bone cancer	0.000198	0.00685	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—CDK4—bone cancer	0.000196	0.00426	CbGpPWpGaD
L-Arginine—SLC22A5—tendon—bone cancer	0.000193	0.0138	CbGeAlD
L-Arginine—ASL—Metabolism—CYP3A4—bone cancer	0.00019	0.00413	CbGpPWpGaD
L-Arginine—Nausea—Cisplatin—bone cancer	0.000189	0.00656	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MMP9—bone cancer	0.000188	0.00409	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—bone cancer	0.000188	0.00408	CbGpPWpGaD
L-Arginine—SLC22A5—spinal cord—bone cancer	0.000186	0.0133	CbGeAlD
L-Arginine—ARG2—Metabolism—DHFR—bone cancer	0.000186	0.00404	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SPARC—bone cancer	0.000182	0.00396	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00018	0.00391	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSTP1—bone cancer	0.000178	0.00386	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Methotrexate—bone cancer	0.000175	0.00606	CcSEcCtD
L-Arginine—ARG2—Metabolism—GNA11—bone cancer	0.000174	0.00378	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Methotrexate—bone cancer	0.000169	0.00586	CcSEcCtD
L-Arginine—NOS3—Metabolism—NDUFA12—bone cancer	0.000167	0.00362	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—GNA11—bone cancer	0.000167	0.00362	CbGpPWpGaD
L-Arginine—Anorexia—Methotrexate—bone cancer	0.000166	0.00578	CcSEcCtD
L-Arginine—Anaphylactic shock—Epirubicin—bone cancer	0.000163	0.00567	CcSEcCtD
L-Arginine—ASL—Metabolism—GSTP1—bone cancer	0.000163	0.00353	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—BRAF—bone cancer	0.00016	0.00348	CbGpPWpGaD
L-Arginine—Tachycardia—Epirubicin—bone cancer	0.000159	0.00553	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—bone cancer	0.000158	0.00548	CcSEcCtD
L-Arginine—ARG2—Metabolism—CYP3A4—bone cancer	0.000158	0.00342	CbGpPWpGaD
L-Arginine—Anorexia—Epirubicin—bone cancer	0.000156	0.00541	CcSEcCtD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000155	0.00337	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—bone cancer	0.000152	0.0033	CbGpPWpGaD
L-Arginine—Decreased appetite—Methotrexate—bone cancer	0.000152	0.00527	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—bone cancer	0.000151	0.00525	CcSEcCtD
L-Arginine—NOS2—Hemostasis—IL3—bone cancer	0.000151	0.00328	CbGpPWpGaD
L-Arginine—Tachycardia—Doxorubicin—bone cancer	0.000148	0.00512	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—bone cancer	0.000146	0.00507	CcSEcCtD
L-Arginine—Anorexia—Doxorubicin—bone cancer	0.000144	0.005	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—bone cancer	0.000142	0.00493	CcSEcCtD
L-Arginine—NOS3—Hemostasis—SPARC—bone cancer	0.000141	0.00307	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ENO2—bone cancer	0.000139	0.00302	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NT5C3A—bone cancer	0.000138	0.003	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTP1—bone cancer	0.000135	0.00293	CbGpPWpGaD
L-Arginine—Decreased appetite—Doxorubicin—bone cancer	0.000131	0.00456	CcSEcCtD
L-Arginine—NOS3—Hemostasis—GNA11—bone cancer	0.000129	0.00281	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—DHFR—bone cancer	0.000129	0.0028	CbGpPWpGaD
L-Arginine—Hypersensitivity—Methotrexate—bone cancer	0.000129	0.00446	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—TP53—bone cancer	0.000128	0.00277	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—JUN—bone cancer	0.000126	0.00274	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000121	0.00262	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GNA11—bone cancer	0.000121	0.00262	CbGpPWpGaD
L-Arginine—Hypersensitivity—Epirubicin—bone cancer	0.00012	0.00418	CcSEcCtD
L-Arginine—NOS3—Hemostasis—IL3—bone cancer	0.000117	0.00255	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—JUN—bone cancer	0.000117	0.00253	CbGpPWpGaD
L-Arginine—Hypersensitivity—Doxorubicin—bone cancer	0.000111	0.00387	CcSEcCtD
L-Arginine—Vomiting—Methotrexate—bone cancer	0.000111	0.00385	CcSEcCtD
L-Arginine—Rash—Methotrexate—bone cancer	0.00011	0.00382	CcSEcCtD
L-Arginine—Dermatitis—Methotrexate—bone cancer	0.00011	0.00382	CcSEcCtD
L-Arginine—Headache—Methotrexate—bone cancer	0.000109	0.0038	CcSEcCtD
L-Arginine—ASS1—Metabolism—CYP3A4—bone cancer	0.000109	0.00237	CbGpPWpGaD
L-Arginine—Vomiting—Epirubicin—bone cancer	0.000104	0.00361	CcSEcCtD
L-Arginine—Nausea—Methotrexate—bone cancer	0.000104	0.0036	CcSEcCtD
L-Arginine—Rash—Epirubicin—bone cancer	0.000103	0.00358	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—bone cancer	0.000103	0.00357	CcSEcCtD
L-Arginine—Headache—Epirubicin—bone cancer	0.000102	0.00355	CcSEcCtD
L-Arginine—NOS2—Hemostasis—PLAU—bone cancer	9.91e-05	0.00215	CbGpPWpGaD
L-Arginine—Nausea—Epirubicin—bone cancer	9.71e-05	0.00337	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—bone cancer	9.61e-05	0.00334	CcSEcCtD
L-Arginine—Rash—Doxorubicin—bone cancer	9.53e-05	0.00331	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—bone cancer	9.53e-05	0.00331	CcSEcCtD
L-Arginine—Headache—Doxorubicin—bone cancer	9.47e-05	0.00329	CcSEcCtD
L-Arginine—ASS1—Metabolism—GSTP1—bone cancer	9.35e-05	0.00203	CbGpPWpGaD
L-Arginine—NOS2—Disease—ENO2—bone cancer	9.31e-05	0.00202	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—bone cancer	9.22e-05	0.002	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—bone cancer	9.16e-05	0.00199	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—bone cancer	8.98e-05	0.00312	CcSEcCtD
L-Arginine—NOS2—Disease—DHFR—bone cancer	8.63e-05	0.00187	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—bone cancer	8.43e-05	0.00183	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—bone cancer	8.34e-05	0.00181	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RGS1—bone cancer	7.85e-05	0.00171	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM4—bone cancer	7.85e-05	0.00171	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLAU—bone cancer	7.7e-05	0.00167	CbGpPWpGaD
L-Arginine—NOS3—Disease—ENO2—bone cancer	7.23e-05	0.00157	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—bone cancer	6.99e-05	0.00152	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM1—bone cancer	6.81e-05	0.00148	CbGpPWpGaD
L-Arginine—NOS3—Disease—DHFR—bone cancer	6.7e-05	0.00146	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFBR2—bone cancer	6.26e-05	0.00136	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ENO2—bone cancer	6.05e-05	0.00131	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—DHFR—bone cancer	5.61e-05	0.00122	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNA11—bone cancer	5.25e-05	0.00114	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFBR2—bone cancer	4.86e-05	0.00106	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—bone cancer	4.84e-05	0.00105	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMO—bone cancer	4.8e-05	0.00104	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP3A4—bone cancer	4.76e-05	0.00103	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNA11—bone cancer	4.39e-05	0.000953	CbGpPWpGaD
L-Arginine—NOS2—Disease—KIT—bone cancer	4.27e-05	0.000927	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ATF1—bone cancer	4.08e-05	0.000886	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTP1—bone cancer	4.07e-05	0.000884	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—bone cancer	4.01e-05	0.000871	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—bone cancer	3.98e-05	0.000865	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL3—bone cancer	3.98e-05	0.000864	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFBR2—bone cancer	3.4e-05	0.000739	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—bone cancer	3.36e-05	0.00073	CbGpPWpGaD
L-Arginine—NOS3—Disease—KIT—bone cancer	3.31e-05	0.00072	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—bone cancer	3.24e-05	0.000704	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1R—bone cancer	3.2e-05	0.000695	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—bone cancer	3.12e-05	0.000677	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—bone cancer	3.09e-05	0.000672	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—bone cancer	2.61e-05	0.000567	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—bone cancer	2.52e-05	0.000547	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KIT—bone cancer	2.32e-05	0.000504	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—bone cancer	2.3e-05	0.000499	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—bone cancer	2.18e-05	0.000474	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—bone cancer	2.11e-05	0.000458	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—bone cancer	1.83e-05	0.000397	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—bone cancer	1.78e-05	0.000387	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JUN—bone cancer	1.59e-05	0.000345	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—bone cancer	1.55e-05	0.000336	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—bone cancer	1.25e-05	0.000271	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—bone cancer	1.05e-05	0.000228	CbGpPWpGaD
